Literature DB >> 33961738

Faecal microbiota transplants: Why do we not consider them as Advanced Therapy Medicinal Products?

Frederick Verbeke1, Bart De Spiegeleer1.   

Abstract

Year:  2021        PMID: 33961738      PMCID: PMC8259247          DOI: 10.1002/ueg2.12066

Source DB:  PubMed          Journal:  United European Gastroenterol J        ISSN: 2050-6406            Impact factor:   4.623


× No keyword cloud information.
  3 in total

1.  Stool for fecal microbiota transplantation should be classified as a transplant product and not as a drug.

Authors:  Josbert J Keller; Maria Jgt Vehreschild; Christian L Hvas; Simon Md Jørgensen; Jouzas Kupciskas; Alexander Link; Chris Jj Mulder; Simon D Goldenberg; Ramesh Arasaradnam; Harry Sokol; Antonio Gasbarrini; Christoph Hoegenauer; Elizabeth M Terveer; Ed J Kuijper; Perttu Arkkila
Journal:  United European Gastroenterol J       Date:  2019-11-14       Impact factor: 4.623

Review 2.  Faecal microbiota transplantation: a regulatory hurdle?

Authors:  Frederick Verbeke; Yorick Janssens; Evelien Wynendaele; Bart De Spiegeleer
Journal:  BMC Gastroenterol       Date:  2017-11-28       Impact factor: 3.067

3.  A standardised model for stool banking for faecal microbiota transplantation: a consensus report from a multidisciplinary UEG working group.

Authors:  Josbert J Keller; Rogier E Ooijevaar; Christian L Hvas; Elisabeth M Terveer; Simone C Lieberknecht; Christoph Högenauer; Perttu Arkkila; Harry Sokol; Oleksiy Gridnyev; Francis Mégraud; Patrizia K Kump; Radislav Nakov; Simon D Goldenberg; Reetta Satokari; Sergiy Tkatch; Maurizio Sanguinetti; Giovanni Cammarota; Andrey Dorofeev; Olena Gubska; Gianluca Laniro; Eero Mattila; Ramesh P Arasaradnam; Shiv K Sarin; Ajit Sood; Lorenza Putignani; Laurent Alric; Simon M D Baunwall; Juozas Kupcinskas; Alexander Link; Abraham G Goorhuis; Hein W Verspaget; Cyriel Ponsioen; Georgina L Hold; Herbert Tilg; Zain Kassam; Ed J Kuijper; Antonio Gasbarrini; Chris J J Mulder; Horace R T Williams; Maria J G T Vehreschild
Journal:  United European Gastroenterol J       Date:  2021-03-09       Impact factor: 4.623

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.